☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
D7220C00001 Trial
AstraZeneca Reports First Patient Vaccinating in P-II/III D7220C00001 Trial for AZD2816 to Prevent COVID-19
June 28, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.